Year |
Citation |
Score |
2016 |
Ramos TN, Arynchyna AA, Blackburn TE, Barnum SR, Johnston JM. Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children. Jci Insight. 1: e87919. PMID 27699221 DOI: 10.1172/Jci.Insight.87919 |
0.544 |
|
2015 |
Johnston JM, Ramos TN, Arynchyna AA, Blackburn TE, Amburgy J, Rocque BG, Blount JP, Rozzelle CJ, Oakes J, Barnum SR. 190 Complement Membrane Attack Complex (MAC) Level in CSF Provides Rapid Identification of Shunt Infection and Failure. Neurosurgery. 62: 229. PMID 26182036 DOI: 10.1227/01.Neu.0000467154.21290.7F |
0.563 |
|
2014 |
Buckingham SC, Ramos TN, Barnum SR. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria. Epilepsia. 55: e139-42. PMID 25385326 DOI: 10.1111/Epi.12858 |
0.615 |
|
2014 |
Szalai AJ, Barnum SR, Ramos TN. Deletion of C-reactive protein ameliorates experimental cerebral malaria? Transactions of the Royal Society of Tropical Medicine and Hygiene. 108: 591-3. PMID 25002461 DOI: 10.1093/Trstmh/Tru098 |
0.584 |
|
2014 |
Ramos TN, Bullard DC, Barnum SR. ICAM-1: isoforms and phenotypes. Journal of Immunology (Baltimore, Md. : 1950). 192: 4469-74. PMID 24795464 DOI: 10.4049/Jimmunol.1400135 |
0.696 |
|
2014 |
Hu X, Patel RP, Weinberg JA, Marques MB, Ramos TN, Barnum SR. Membrane attack complex generation increases as a function of time in stored blood. Transfusion Medicine (Oxford, England). 24: 114-6. PMID 24588971 DOI: 10.1111/Tme.12109 |
0.535 |
|
2014 |
Bullard DC, Hu X, Crawford D, McDonald K, Ramos TN, Barnum SR. Expression of a single ICAM-1 isoform on T cells is sufficient for development of experimental autoimmune encephalomyelitis. European Journal of Immunology. 44: 1194-9. PMID 24435747 DOI: 10.1002/Eji.201344023 |
0.629 |
|
2014 |
Hu X, Wetsel RA, Ramos TN, Mueller-Ortiz SL, Schoeb TR, Barnum SR. Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis. Immunobiology. 219: 104-8. PMID 24028840 DOI: 10.1016/J.Imbio.2013.08.007 |
0.696 |
|
2013 |
Ramos TN, Bullard DC, Darley MM, McDonald K, Crawford DF, Barnum SR. Experimental cerebral malaria develops independently of endothelial expression of intercellular adhesion molecule-1 (icam-1). The Journal of Biological Chemistry. 288: 10962-6. PMID 23493396 DOI: 10.1074/Jbc.C113.457028 |
0.63 |
|
2013 |
Hu X, Holers VM, Thurman JM, Schoeb TR, Ramos TN, Barnum SR. Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE. Molecular Immunology. 54: 302-8. PMID 23337717 DOI: 10.1016/J.Molimm.2012.12.018 |
0.619 |
|
2012 |
Ramos TN, Bullard DC, Barnum SR. Deletion of the complement phagocytic receptors CR3 and CR4 does not alter susceptibility to experimental cerebral malaria. Parasite Immunology. 34: 547-50. PMID 22882618 DOI: 10.1111/Pim.12002 |
0.62 |
|
2012 |
Darley MM, Ramos TN, Wetsel RA, Barnum SR. Deletion of carboxypeptidase N delays onset of experimental cerebral malaria. Parasite Immunology. 34: 444-7. PMID 22708514 DOI: 10.1111/J.1365-3024.2012.01376.X |
0.716 |
|
2012 |
Ramos TN, Darley MM, Weckbach S, Stahel PF, Tomlinson S, Barnum SR. The C5 convertase is not required for activation of the terminal complement pathway in murine experimental cerebral malaria. The Journal of Biological Chemistry. 287: 24734-8. PMID 22689574 DOI: 10.1074/Jbc.C112.378364 |
0.666 |
|
2011 |
Ramos TN, Darley MM, Hu X, Billker O, Rayner JC, Ahras M, Wohler JE, Barnum SR. Cutting edge: the membrane attack complex of complement is required for the development of murine experimental cerebral malaria. Journal of Immunology (Baltimore, Md. : 1950). 186: 6657-60. PMID 21572031 DOI: 10.4049/Jimmunol.1100603 |
0.73 |
|
2011 |
Hu XZ, Wright TT, Jones NR, Ramos TN, Skibinski GA, McCrory MA, Barnum SR, Szalai AJ. Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent. Autoimmune Diseases. 2011: 484936. PMID 21151582 DOI: 10.4061/2011/484936 |
0.679 |
|
2009 |
Ramos TN, Wohler JE, Barnum SR. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis. Neuroscience Letters. 467: 234-6. PMID 19850104 DOI: 10.1016/J.Neulet.2009.10.045 |
0.716 |
|
Show low-probability matches. |